Inventor · disambiguated record
Callum Sloss
Also filed as: SLOSS CALLUM · SLOSS CALLUM M
2 granted patents·7 pending applications·2 citations·filing 2017–2023
41Inventor score
Top patents by PatentIndex Score
9 records- 0174US11701428B2Therapeutic combinations comprising anti-CD123 immunoconjugatesIMMUNOGEN INC·Filed 2020·Granted Jul 18, 2023·1 cites·40 claims
- 0272US11278629B2Methods for improving anti-CD37 immunoconjugate therapyDEBIOPHARM INT SA·Filed 2017·Granted Mar 22, 2022·1 cites·26 claims
- 0363US2024033371A1Therapeutic combinations comprising anti-cd123 immunoconjugatesIMMUNOGEN INC·Filed 2023·Application pending·0 cites
- 0460US2024226312A1Treatment of cancer in patients with soluble fr-alphaIMMUNOGEN INC·Filed 2022·Application pending·0 cites
- 0560US2023112620A1Treatment of cancer in patients with soluble fr-alphaIMMUNOGEN INC·Filed 2022·Application pending·0 cites
- 0656US2023312735A1Methods of treatment using anti-cd123 immunoconjugatesIMMUNOGEN INC·Filed 2022·Application pending·0 cites
- 0753US2020157228A1Methods of treatment using anti-cd123 immunoconjugatesIMMUNOGEN INC·Filed 2019·Application pending·0 cites
- 0851US2024165256A1Methods for increasing efficacy of immunoconjugates targeting adam9 for the treatment of cancerIMMUNOGEN INC·Filed 2022·Application pending·0 cites
- 0940US2019160089A1Combination treatment with antibody-drug conjugates and cytarabineIMMUNOGEN INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Callum Sloss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →